EZR and osteosarcoma: Our findings also demonstrated that patients with grade III-IV osteosarcoma showed a higher frequency of ezrin expression than those with grade I-II osteosarcoma (OR = 2.49, 95% CI = 1.33~4.69, P = 0.005).